Aktive Positionen von Jens Kjeldsen-Kragh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Technik-/Wissenschafts-/F&E-Leiter | 15.04.2010 | - |
| Gründer | 01.01.2008 | - |
Karriereverlauf von Jens Kjeldsen-Kragh
Ehemalige bekannte Positionen von Jens Kjeldsen-Kragh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Oslo | Corporate Officer/Principal | - | - |
Statistik
International
| Norwegen | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Börse
- Insiders
- Jens Kjeldsen-Kragh
- Erfahrung
